Dybbs Michael
SEC-identified person · CIK 1601264 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Nkarta, Inc. NKTX | Director | filed 2020–2026 |
| Sutro Biopharma, INC. STRO | Director | filed 2018–2026 |
| Kalaris Therapeutics, Inc. KLRS | Director | filed 2025–2026 |
| Spyglass Pharma, Inc. SPG | Director | filed 2026–2026 |
| Dimension Therapeutics, Inc. DMTX | Director | filed 2015–2017 |
| Versartis, Inc. VSAR | Director | filed 2014–2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.